Dopamine replacement therapy does not restore the ability of Parkinsonian patients to make rapid adjustments in motor strategies according to changing sensorimotor contexts

Parkinsonism and Related Disorders

Volumn 13, Issue 7, 2007, Pages 425-433

  Tunik, E ^a   Feldman, A G ^b   Poizner, H ^c  

^a NEW YORK UNIVERSITY   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Adaptive motor control; Basal ganglia; Dopamine medication; Parkinson's disease

Indexed keywords

ADOMIN; AMANTADINE; AMITRIPTYLINE; CARBIDOPA PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; MINAPRIL; PAROXETINE; PRAMIPEXOLE; ROPINIROLE; SELEGILINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FUNCTIONAL ASSESSMENT; HAND MOVEMENT; HUMAN; KINEMATICS; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; SPINE MOBILITY; SUBSTITUTION THERAPY;

ADAPTATION, PHYSIOLOGICAL; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; BIOMECHANICS; DOPAMINE; EXERCISE MOVEMENT TECHNIQUES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOVEMENT; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE;

EID: 34548829115     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.02.003     Document Type: Article

References (44)

1. Sarazin M., Deweer B., Merkl A., Von Poser N., Pillon B., and Dubois B. Procedural learning and striatofrontal dysfunction in Parkinson's disease. Mov Disord 17 2 (2002) 265-273
2. Krebs H.I., Hogan N., Hening W., Adamovich S.V., and Poizner H. Procedural motor learning in Parkinson's disease. Exp Brain Res 141 4 (2001) 425-437
3. Graybiel A.M., Aosaki T., Flaherty A.W., and Kimura M. The basal ganglia and adaptive motor control. Science 265 5180 (1994) 1826-1831
4. Obeso J.A., Rodriguez-Oroz M.C., Lanciego J.L., and Rodriguez Diaz M. How does Parkinson's disease begin? The role of compensatory mechanisms. Trends Neurosci 27 3 (2004) 125-127 author reply 127-8
5. Tunik E., Adamovich S.V., Poizner H., and Feldman A.G. Deficits in rapid adjustments of movements according to task constraints in Parkinson's disease. Mov Disord 19 8 (2004) 897-906
6. Tunik E., Poizner H., Adamovich S.V., Levin M.F., and Feldman A.G. Deficits in adaptive upper limb control in response to trunk perturbations in Parkinson's disease. Exp Brain Res 159 1 (2004) 23-32
7. Desmurget M., Gaveau V., Vindras P., Turner R.S., Broussolle E., and Thobois S. On-line motor control in patients with Parkinson's disease. Brain 127 Pt 8 (2004) 1755-1773
8. Inzelberg R., Plotnik M., Flash T., Schechtman E., Shahar I., and Korczyn A.D. Mental and motor switching in Parkinson's disease. J Mot Behav 33 4 (2001) 377-385
9. Bouchard S. Optimum symptomatic control of Parkinson's disease with dopaminergic therapy. Can J Neurol Sci 14 Suppl. 3 (1987) 460-465
10. Olanow C.W., Nakano K., Nausieda P., Tetrud J.A., Manyam B., Last B., et al. An open multicenter trial of Sinemet CR in levodopa-naive Parkinson's disease patients. Clin Neuropharmacol 14 3 (1991) 235-240
11. Feigin A., Ghilardi M.F., Fukuda M., Mentis M.J., Dhawan V., Barnes A., et al. Effects of levodopa infusion on motor activation responses in Parkinson's disease. Neurology 59 2 (2002) 220-226
12. Alam M., and Schmidt W.J. L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats. Behav Brain Res 153 2 (2004) 439-446
13. Xia R., and Rymer W.Z. The role of shortening reaction in mediating rigidity in Parkinson's disease. Exp Brain Res 156 4 (2004) 524-528
14. Burleigh A., Horak F., Nutt J., and Frank J. Levodopa reduces muscle tone and lower extremity tremor in Parkinson's disease. Can J Neurol Sci 22 4 (1995) 280-285
15. Schettino L.F., Adamovich S.V., Hening W., Tunik E., Sage J., and Poizner H. Hand preshaping in Parkinson's disease: effects of visual feedback and medication state. Exp Brain Res 168 1-2 (2006) 186-202
16. Negrotti A., Secchi C., and Gentilucci M. Effects of disease progression and L-dopa therapy on the control of reaching-grasping in Parkinson's disease. Neuropsychologia 43 3 (2005) 450-459
17. Kelly V.E., Hyngstrom A.S., Rundle M.M., and Bastian A.J. Interaction of levodopa and cues on voluntary reaching in Parkinson's disease. Mov Disord 17 1 (2002) 38-44
18. Melvin K.G., Doan J., Pellis S.M., Brown L., Whishaw I.Q., and Suchowersky O. Pallidal deep brain stimulation and L-dopa do not improve qualitative aspects of skilled reaching in Parkinson's disease. Behav Brain Res 160 1 (2005) 188-194
19. Buhmann C., Glauche V., Sturenburg H.J., Oechsner M., Weiller C., and Buchel C. Pharmacologically modulated fMRI-cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients. Brain 126 Pt 2 (2003) 451-461
20. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9 1 (1971) 97-113
21. Defer G.L., Widner H., Marie R.M., Remy P., and Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 14 4 (1999) 572-584
22. Forjaz M.J., and Martinez-Martin P. Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: part II, construct and content validity. Mov Disord 21 11 (2006) 1892-1898
23. Stebbins G.T., and Goetz C.G. Factor structure of the unified Parkinson's disease rating scale: motor examination section. Mov Disord 13 4 (1998) 633-636
24. Stebbins G.T., Goetz C.G., Lang A.E., and Cubo E. Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off-state. Mov Disord 14 4 (1999) 585-589
25. Ramaker C., Marinus J., Stiggelbout A.M., and Van Hilten B.J. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Mov Disord 17 5 (2002) 867-876
26. Martinez-Martin P., and Forjaz M.J. Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: part I, feasibility, scaling assumptions, reliability, and precision. Mov Disord 21 8 (2006) 1182-1188
27. Martinez-Martin P., Prieto L., and Forjaz M.J. Longitudinal metric properties of disability rating scales for Parkinson's disease. Value Health 9 6 (2006) 386-393
28. States R.A., and Pappas E. Precision and repeatability of the Optotrak 3020 motion measurement system. J Med Eng Technol 30 1 (2006) 11-16
29. Tresilian J.R., Stelmach G.E., and Adler C.H. Stability of reach-to-grasp movement patterns in Parkinson's disease. Brain 120 Pt 11 (1997) 2093-2111
30. Teulings H.L., Contreras-Vidal J.L., Stelmach G.E., and Adler C.H. Parkinsonism reduces coordination of fingers, wrist, and arm in fine motor control. Exp Neurol 146 1 (1997) 159-170
31. Kitazawa S.G.T., and Urushihara Y. Quantitative Evaluation of Reaching Movements in Cats with and Without Cerebellar Lesions Using Normalized Integral of Jerk (1993), Elsevier, Amsterdam
32. Boraud T., Bezard E., Bioulac B., and Gross C.E. Ratio of inhibited-to-activated pallidal neurons decreases dramatically during passive limb movement in the MPTP-treated monkey. J Neurophysiol 83 3 (2000) 1760-1763
33. Pessiglione M., Guehl D., Rolland A.S., Francois C., Hirsch E.C., Feger J., et al. Thalamic neuronal activity in dopamine-depleted primates: evidence for a loss of functional segregation within basal ganglia circuits. J Neurosci 25 6 (2005) 1523-1531
34. Escola L., Michelet T., Douillard G., Guehl D., Bioulac B., and Burbaud P. Disruption of the proprioceptive mapping in the medial wall of parkinsonian monkeys. Ann Neurol 52 5 (2002) 581-587
35. Maschke M., Gomez C.M., Tuite P.J., and Konczak J. Dysfunction of the basal ganglia, but not the cerebellum, impairs kinaesthesia. Brain 126 Pt 10 (2003) 2312-2322
36. Klockgether T., Borutta M., Rapp H., Spieker S., and Dichgans J. A defect of kinesthesia in Parkinson's disease. Mov Disord 10 4 (1995) 460-465
37. Adamovich S.V., Berkinblit M.B., Hening W., Sage J., and Poizner H. The interaction of visual and proprioceptive inputs in pointing to actual and remembered targets in Parkinson's disease. Neuroscience 104 4 (2001) 1027-1041
38. Jenkins I.H., Fernandez W., Playford E.D., Lees A.J., Frackowiak R.S., Passingham R.E., et al. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurol 32 6 (1992) 749-757
39. Haslinger B., Erhard P., Kampfe N., Boecker H., Rummeny E., Schwaiger M., et al. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 124 Pt 3 (2001) 558-570
40. Fattapposta F., Pierelli F., My F., Mostarda M., Del Monte S., Parisi L., et al. L-dopa effects on preprogramming and control activity in a skilled motor act in Parkinson's disease. Clin Neurophysiol 113 2 (2002) 243-253
41. Boudreau M.J., Brochier T., Pare M., and Smith A.M. Activity in ventral and dorsal premotor cortex in response to predictable force-pulse perturbations in a precision grip task. J Neurophysiol 86 3 (2001) 1067-1078
42. Brasted P.J., and Wise S.P. Comparison of learning-related neuronal activity in the dorsal premotor cortex and striatum. Eur J Neurosci 19 3 (2004) 721-740
43. Buch E.R., Brasted P.J., and Wise S.P. Comparison of population activity in the dorsal premotor cortex and putamen during the learning of arbitrary visuomotor mappings. Exp Brain Res 169 1 (2006) 69-84
44. Clower D.M., Dum R.P., and Strick P.L. Basal ganglia and cerebellar inputs to 'AIP'. Cereb Cortex 15 7 (2005) 913-920